Skip to main content
. 2021 Jul 5;27(1):127–140. doi: 10.1038/s41380-021-01197-9

Fig. 1. Overview of topmost implicated plasma proteins of the complement and coagulation pathways identified in two or more studies.

Fig. 1

Number of studies showing altered complement proteins in A longitudinal conversion and CHR-transition studies, B longitudinal general population studies of the ALSPAC cohort, C case-control psychosis studies, and D case-control psychosis spectrum studies. Number of studies showing altered coagulation proteins in E longitudinal conversion and CHR-transition studies, F longitudinal general population studies of the ALSPAC cohort, G case-control psychosis studies, and H case–control psychosis spectrum studies. Positive or negative depiction indicates direction of fold change found in each study, e.g., a mention of −2 means that two studies found this protein to be downregulated, threshold indicated as two studies.